癌症是导致人类死亡的主要原因之一，2022年全球和中国分别约有1000万人和320万人死于癌症。尽管在过去几十年中已经进行了大量研究，但人们对癌症生物学的许多基本问题仍然知之甚少，包括从恶性肿瘤前期到肿瘤的转变、克隆进化和可塑性、肿瘤内异质性、肿瘤与基质的相互作用、转移机制、治疗耐药性和免疫微环等。因此，对癌症特性的全面分析和解释不仅需要精确的研究，还需要全球范围内的共同努力。
CIMR国际肿瘤论坛的目标是汇集世界领先的癌症生物学家和医师科学家，讨论该领域的最新发展、前沿和热点问题，鼓励来自各个专业水平的参会者通过参与讨论做出贡献。我们希望CIMR国际肿瘤论坛能成为一个互动的平台，从而促进合作，解决癌症研究中最具挑战性的问题。
Session I: Cancer immune signaling
Mechanisms underlying responsiveness and resistance to cancer immunotherapy
New strategies for targeted cancer immunotherapy
The past, present and future of a germline variant in IgG1 coding gene IGHG1
Regulation CD8 T cell dynamics and function in cancer
Session II: Cancer metabolism
Disrupted niche function for normal hematopoiesis in AML is restorable with IL-1R antagonist therapy
Metabolic reprogramming and immune evasion in cancer
Exploiting phospholipid remodeling pathways for cancer treatment
Rewired metabolism as a targetable liability of IDH-mutant leukemia
Session III: New technologies and approaches in cancer research
Big data and artificial intelligence: catalysts for innovation in medicine and healthcare
Radiopharmaceuticals and radiotherapy-activated prodrugs
Innovative oncology therapies based on diverse modalities and translational disease insights
Exploration of macrophages as therapeutic targets in cancer treatment
Session IV: Genome maintenance systems in cancer
Cancer-causing pathogens, cell plasticity and upper GI cancers
The formation of DNA replication-coupled chromatin structures
A tango between STING and TRPV2 on the ER: genome protection and immune regulation
北京市丰台区右安门外西头条10号
010-86738999
cimr@cimrbj.ac.cn
En
